US Patent 11786546 Compounds and methods for modulating GFAP
Patent 11786546 was granted and assigned to Ionis Pharmaceuticals, Inc. on October, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11786546 Compounds and methods for modulating GFAP
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
